HHLA2 and neoplasm: In gastric cancer, lower levels of HHLA2 mRNA in the blood was reportedly associated with tumor aggressiveness, adverse prognosis, and lesser 5-year survival rates [16], whereas the overexpression of HHLA2 in cancer tissues was correlated with poor overall survival [17].